SpectraScience Inc. (OTCBB: SCIE) is a designer, developer and manufacturer of light-based analysis systems capable of determining whether tissue is normal, pre-cancerous or cancerous without removing physical tissue from the body. With the ability to streamline cancer biopsies, the technology could revolutionize the multi-billion dollar cancer screening market. The company’s WavSTAT Optical Biopsy System^® is a Laser Induced Fluorescence (LIF) spectrophotometry system that uses a proprietary algorithm to detect "spectral signatures" in tissue to determine whether or not it’s cancerous. With a CE mark in the European Union, the device is already being marketed and sold by its distributor, PENTAX Europe.